Page 108«..1020..107108109110..120130..»

Category Archives: Global News Feed

Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022

Posted: May 15, 2022 at 2:13 am

Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022.

Read the original:
Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022

Posted in Global News Feed | Comments Off on Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2022

The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET

Posted: May 15, 2022 at 2:13 am

AMITYVILLE, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) (“Greenrose” or the “Company”), a multi-state grower and producer of cannabis brands and products, will hold a conference call on Monday, May 16, 2022 at 5:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2022. The Company will provide its financial results in a press release prior to the conference call.

Continued here:
The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET

Posted in Global News Feed | Comments Off on The Greenrose Holding Company to Hold First Quarter 2022 Conference Call on May 16, 2022 at 5:30 p.m. ET

Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments

Posted: May 15, 2022 at 2:13 am

CINCINNATI, May 13, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), today announced its financial results for the first quarter ended March 31, 2022 and provided an update on recent business developments and progress. Blue Water Vaccines is a pre-clinical stage biotechnology company developing vaccines against multiple infectious diseases, including influenza, norovirus, rotavirus, and acute otitis media (AOM) from Streptococcus pneumoniae colonization.

Go here to see the original:
Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments

Posted in Global News Feed | Comments Off on Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments

Zosano Pharma Reports First Quarter 2022 Financial Results

Posted: May 15, 2022 at 2:13 am

FREMONT, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022. All share and per share information included in these financial results and statements has been retroactively adjusted to give effect to our April 11, 2022 1-for-35 reverse stock split.

Go here to read the rest:
Zosano Pharma Reports First Quarter 2022 Financial Results

Posted in Global News Feed | Comments Off on Zosano Pharma Reports First Quarter 2022 Financial Results

Calliditas Therapeutics Launches an Online Patient Platform

Posted: May 15, 2022 at 2:13 am

This launch coincides with the inaugural IgAN Awareness Day This launch coincides with the inaugural IgAN Awareness Day

Read the original:
Calliditas Therapeutics Launches an Online Patient Platform

Posted in Global News Feed | Comments Off on Calliditas Therapeutics Launches an Online Patient Platform

Zosano Pharma Provides Corporate Update

Posted: May 2, 2022 at 2:43 am

FREMONT, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today provided a corporate update.

See the article here:
Zosano Pharma Provides Corporate Update

Posted in Global News Feed | Comments Off on Zosano Pharma Provides Corporate Update

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies…

Posted: May 2, 2022 at 2:43 am

COPENHAGEN, Denmark, April 29, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

Read more here:
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies...

Posted in Global News Feed | Comments Off on Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies…

Dividend approval

Posted: May 2, 2022 at 2:43 am

Press release

Here is the original post:
Dividend approval

Posted in Global News Feed | Comments Off on Dividend approval

Kane Biotech Announces Extension of Private Placement Offering

Posted: May 2, 2022 at 2:43 am

Not for distribution to U.S. news wire services or dissemination in the United States

The rest is here:
Kane Biotech Announces Extension of Private Placement Offering

Posted in Global News Feed | Comments Off on Kane Biotech Announces Extension of Private Placement Offering

CORRECTION – Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022

Posted: May 2, 2022 at 2:43 am

REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Coherus BioSciences, Inc. (Nasdaq: CHRS), please note in the Conference Call Information, the start time should be 4:30 p.m. ET, not 5 p.m. ET as previously stated. The corrected release follows:

The rest is here:
CORRECTION - Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022

Posted in Global News Feed | Comments Off on CORRECTION – Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022

Page 108«..1020..107108109110..120130..»